[1]
S. Chopra, “Protocol for an integrated phase II/III randomised controlled trial of transarterial chemotherapy and sorafenib with or without stereotactic body radiation therapy in patients with nonmetastatic unresectable hepatocellular carcinoma”, Int J Clin Trials, vol. 4, no. 1, pp. 31–38, Jan. 2017.